Skip to main content

Table 3 Effects of probiotic supplementation on anthropometric measures, body composition and laboratory measurements

From: Effect of probiotic supplementation on lipoprotein-associated phospholipase A2 in type 2 diabetic patients: a randomized double blind clinical controlled trial

Variables

Probiotic (n = 34)

Placebo (n = 34)

P values

Baseline

After

Change

Baseline

After

Change

Time

Group

Time * Group

Weight (kg)

81±11.06

81.5±12

0.5

77.9±11.4

77.7±11.2

0.2

0.94

0.35

0.72

BMI (kg/m2)

31.2±3.3

30.4±6.3

0.8

31.1±3.4

31.01±3.5

0.09

0.96

0.6

0.11

WC (cm)

105.7±8.2

101.4±19.3

4.3

105.8±9.6

105.56±9.5

0.24

0.65

0.95

0.2

FM (kg)

28.2±7

27.3±8

0.9

28.9±6.6

28.87±6.7

0.03

0.04

0.86

0.42

FFM (kg)

52±9.8

53.7±11

1.7

49.07±8.1

48.8±7.7

0.27

0.9

0.08

0.07

FBS (mg/dl)

207±74

176±53

31

184.6±57

176.5±52

8.1

0.44

0.37

0.06

HbA1c (%)

9.9±2.4

8.4±1.4

1.5

8.36±1.6

8.33±1.3

0.03

0.98

0.09

< 0.001*

Insulin(µU/mL)

16.9±13.4

15.3±7.4

1.6

22.27±19.6

23.1±21

-0.83

0.56

0.22

0.28

HOMA-IR

7.85±5.3

6.7±5.1

1.15

10.48±9.6

10.49±10.3

-0.01

0.3

0.21

0.26

TC(mg/dl)

186±50

181±40

5.586

168±36

169±28

-1.65

0.37

0.06

0.42

LDL(mg/dl)

131.75±43

117±37

14.694

108.15±38

107.47±30

0.68

0.6

0.06

0.08

HDL(mg/dl)

38±8

44±8.5

-6

40.3±8.8

41.6±9.2

-1.3

0.87

0.78

0.005*

TG(mg/dl)

152.3±68

141.7±60

10.6

128.5±55

135.85±59

-7.35

0.76

0.1

0.16

Lp-PLA2(ng/ml)

47.4±7.5

41±7

6.4

46.13±7.1

47.3±7.5

-1.17

0.3

0.16

< 0.001*

  1. BMI body mass index, FM; fat mass, FFM; fat free mass, FBS fasting blood sugar, HbA1c glycated hemoglobin, HOMA-IR homeostasis model assessment-estimated insulin resistance, TC total cholesterol, TG: Triglyceride, HDL: High Density of Lipoprotein, LDL: Low Density of Lipoprotein, Lp-PLA2 lipoprotein phospholipase A2, * Significant difference (p < 0.05). Data are presented as Mean ±SD, Statistic test; repeated measure analysis of variance